Public Health - Expensive Drugs - Manufacturer Reporting and Drug Price Transparency Advisory Committee

HB 666 Public Health Expensive Drugs Manufacturer Reporting and Drug Price Transparency Advisory Committee

Maryland 2017 Regular Session

Bill Texts

Introduced 02/01/2017

Weigh In


Sponsors (74)